Global Manufacturing of CAR T Cell Therapy

Immunotherapy using chimeric antigen receptor-modified T cells has demonstrated high response rates in patients with B cell malignancies, and chimeric antigen receptor T cell therapy is now being investigated in several hematologic and solid tumor types. Chimeric antigen receptor T cells are generat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bruce L. Levine, James Miskin, Keith Wonnacott, Christopher Keir
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2017-03-01
Sarja:Molecular Therapy: Methods & Clinical Development
Aiheet:
chimeric antigen receptor
T lymphocytes
manufacturing
lentiviral vector
global regulatory environment
Linkit:http://www.sciencedirect.com/science/article/pii/S2329050116302029
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia